NO920176L - Antagonister av gm-csf avledet fra karboksylterminalen - Google Patents

Antagonister av gm-csf avledet fra karboksylterminalen

Info

Publication number
NO920176L
NO920176L NO92920176A NO920176A NO920176L NO 920176 L NO920176 L NO 920176L NO 92920176 A NO92920176 A NO 92920176A NO 920176 A NO920176 A NO 920176A NO 920176 L NO920176 L NO 920176L
Authority
NO
Norway
Prior art keywords
carboxyl terminal
csf antagonists
antagonists derived
derived
csf
Prior art date
Application number
NO92920176A
Other languages
English (en)
Norwegian (no)
Other versions
NO920176D0 (no
Inventor
Gail Foure Seelig
Julie Ellen Scheffler
Paul Phillip Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO920176D0 publication Critical patent/NO920176D0/no
Publication of NO920176L publication Critical patent/NO920176L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
NO92920176A 1989-07-14 1992-01-14 Antagonister av gm-csf avledet fra karboksylterminalen NO920176L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37984689A 1989-07-14 1989-07-14
PCT/US1990/003811 WO1991001330A1 (en) 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus

Publications (2)

Publication Number Publication Date
NO920176D0 NO920176D0 (no) 1992-01-14
NO920176L true NO920176L (no) 1992-01-14

Family

ID=23498958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920176A NO920176L (no) 1989-07-14 1992-01-14 Antagonister av gm-csf avledet fra karboksylterminalen

Country Status (16)

Country Link
US (1) US5475087A (hu)
EP (2) EP0409091A1 (hu)
JP (1) JPH04503815A (hu)
KR (1) KR920701246A (hu)
AU (1) AU630496B2 (hu)
CA (1) CA2062975A1 (hu)
FI (1) FI920150A0 (hu)
HU (1) HUT63181A (hu)
IE (1) IE902562A1 (hu)
IL (1) IL95061A0 (hu)
MY (1) MY105946A (hu)
NO (1) NO920176L (hu)
NZ (1) NZ234479A (hu)
PH (1) PH27534A (hu)
WO (1) WO1991001330A1 (hu)
ZA (1) ZA905480B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060741A1 (en) * 1991-02-11 1992-08-12 Robert S. Greenfield Gm-csf inhibiting oligopeptides
CA2149881A1 (en) * 1992-11-19 1994-05-26 Paul T. Jubinsky Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) * 1995-02-08 1997-07-11 Stephanois Rech Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) * 1995-06-23 1995-07-20 Bresagen Limited Haemopoietic growth factor antagonists and uses therefor
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US8062637B2 (en) * 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
AU2005100402B4 (en) * 2005-05-16 2006-01-12 Novomatic Ag Method for increased chances at an award on a Gaming Machine
AU2013201228B2 (en) * 2006-02-08 2016-01-21 Eisai, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
KR101486183B1 (ko) 2006-02-08 2015-01-28 모르포테크, 인크. 항원성 ｇｍ-ｃｓｆ 펩티드 및 ｇｍ-ｃｓｆ에 대한 항체
US8398972B2 (en) 2006-11-21 2013-03-19 Kalobios Pharmaceuticals, Inc. Methods of treating dementia using a GM-CSF antagonist
BRPI0719109A2 (pt) * 2006-11-21 2013-12-10 Kalobios Pharmaceuticals Inc Métodos para tratar doenças inflamatórias crônicas usando um antagonista de gm-csf
TW200918553A (en) 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
EP2215119B1 (en) 2007-11-13 2012-12-26 Evec Inc. Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
RU2011127334A (ru) 2008-12-22 2013-01-27 Де Юниверсити Оф Мельбурн Лечение остеоартрита
EP3381471B1 (en) 2008-12-22 2024-03-20 The University of Melbourne Pain treatment
US9901079B2 (en) 2011-08-18 2018-02-27 New York University Inhibition of oncogenic kras-induced GM-CSF production and function
JP6426001B2 (ja) * 2011-11-17 2018-11-21 グリア エスピー ゼット．オー．オー． 神経膠腫を治療するための組成物および方法
BR112023016350A2 (pt) 2021-02-15 2023-11-14 Splifar S A Método para aplicação de uma vedação em uma placa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ATE67244T1 (de) * 1984-07-06 1991-09-15 Sandoz Ag Herstellung und reinigung von lymphokinen.
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
US5475087A (en) 1995-12-12
HUT63181A (en) 1993-07-28
ZA905480B (en) 1991-03-27
EP0409091A1 (en) 1991-01-23
AU630496B2 (en) 1992-10-29
CA2062975A1 (en) 1991-01-15
AU6148790A (en) 1991-02-22
JPH04503815A (ja) 1992-07-09
NO920176D0 (no) 1992-01-14
FI920150A0 (fi) 1992-01-14
PH27534A (en) 1993-08-18
EP0482086A1 (en) 1992-04-29
IL95061A0 (en) 1991-06-10
NZ234479A (en) 1992-03-26
IE902562A1 (en) 1991-02-27
HU9200087D0 (en) 1992-04-28
WO1991001330A1 (en) 1991-02-07
MY105946A (en) 1995-02-28
KR920701246A (ko) 1992-08-11

Similar Documents

Publication Publication Date Title
NO920176L (no) Antagonister av gm-csf avledet fra karboksylterminalen
DE69005755T2 (de) Strommessschaltung.
DE69131712D1 (de) Lottragender anschlussdraht
DE69011756T2 (de) Stromspiegelschaltung.
FI913251A0 (fi) Renad kiliarisk neurotrofisk faktor.
NO178643C (no) Klemmekonstruksjon
BR8800710A (pt) Supressor de sobretensoes
ATA247090A (de) Klemmanordnung
DE59204995D1 (de) Anschlussklemme
DE69320749T2 (de) Strommessschaltung
DE69007708T2 (de) Drahtverbindungsapparat.
NO890904D0 (no) Video-terminal.
BR9005427A (pt) Prendedor terminal
ATE132871T1 (de) Bis-arylphosphatester-antagonisten vom thrombocyten aktivierenden faktor
NO901257D0 (no) Kinolinderivater.
DE69029922T2 (de) Bi-CMOS-Schaltung
FR2609585B1 (fr) Circuit realisant la fonction ou-exclusif
DK0418863T3 (da) NMDA-antagonister
FI922315A (fi) Jännitteenmittauspiiri
DE69011695T2 (de) Hochspannungsverbindungsdraht.
DE69116328T2 (de) Vorverdrahtbare Anschlussleiste
KR920001492U (ko) 개량형 접속단자
KR910003471U (ko) 단자함
KR910008022U (ko) 터미날
ES1010521Y (es) Caja terminal.